Literature DB >> 23321646

Megakaryocytic differentiation of CD133+ hematopoietic stem cells by down-regulation of microRNA-10a.

M Nikougoftar Zarif1, M Soleimani, H Abolghasemi, N Amirizade, E Arefian, A Rahimian.   

Abstract

MicroRNAs (miRNA), as a class of non-coding RNAs, play a crucial role in normal hematopoiesis. Recent studies on miRNA profiling during hematopoiesis showed miR-10a down-regulation in megakaryocytic differentiation. Here we investigated whether decrease in miR-10a can differentiate umbilical cord blood CD133+ cells to megakaryocytic series. We ectopically induced miR-10a down-regulation by locked nucleic acid anti-miR-10a transfection of CD133+ cells. The megakaryocytic differentiation was evaluated by CD42/CD61 and CD41 surface expression and colonogenic capacity in Megacult media. In addition, real-time polymerase chain reaction was done for detection of miR-10a and its target HoxA1 mRNA. HOXA1 protein expression was detected by flow cytometry as mean fluorescent intensity that shows the antibody reaction proteins. Our findings showed megakaryocytic differentiation of about 28% of umbilical cord blood CD133+ stem cells with bright expression of CD42/CD61 and CD41 in parallel with increase in HoxA1 mRNA and protein level. Colony forming of CD61+ cells in Megacult demonstrated the colonogenic capacity of differentiated progenitor cells. In conclusion, MiR-10a has a role in megakaryocyte differentiation of stem cells via HOXA1 transcription factor targeting.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23321646     DOI: 10.1179/1607845412Y.0000000047

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  6 in total

1.  Identifying microRNA determinants of human myelopoiesis.

Authors:  Megha Rajasekhar; Ulf Schmitz; Stephane Flamant; Justin J-L Wong; Charles G Bailey; William Ritchie; Jeff Holst; John E J Rasko
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

2.  MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation.

Authors:  Luciana De Luca; Stefania Trino; Ilaria Laurenzana; Vittorio Simeon; Giovanni Calice; Stefania Raimondo; Marina Podestà; Michele Santodirocco; Lazzaro Di Mauro; Francesco La Rocca; Antonella Caivano; Annalisa Morano; Francesco Frassoni; Daniela Cilloni; Luigi Del Vecchio; Pellegrino Musto
Journal:  Oncotarget       Date:  2016-02-09

3.  Nanochelating based nanocomplex, GFc7, improves quality and quantity of human mesenchymal stem cells during in vitro expansion.

Authors:  Maryam Hafizi; Atena Hajarizadeh; Amir Atashi; Somayeh Kalanaky; Saideh Fakharzadeh; Zahra Masoumi; Mohammad Hassan Nazaran; Masoud Soleimani
Journal:  Stem Cell Res Ther       Date:  2015-11-23       Impact factor: 6.832

4.  MicroRNA Microarray Profiling during Megakaryocyte Differentiation of Cord Blood CD133+ Hematopoietic Stem Cells.

Authors:  Mohammad Houshmand; Mozhde Nakhlestani Hagh; Masoud Soleimani; Amir Ali Hamidieh; Saeed Abroun; Mahin Nikougoftar Zarif
Journal:  Cell J       Date:  2018-03-18       Impact factor: 2.479

5.  Transcriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8.

Authors:  Pattarin Tangtanatakul; Boonyakiat Thammasate; Alain Jacquet; Rangsima Reantragoon; Trairak Pisitkun; Yingyos Avihingsanon; Asada Leelahavanichkul; Nattiya Hirankarn
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

6.  Hemmule: A Novel Structure with the Properties of the Stem Cell Niche.

Authors:  Vitaly Vodyanoy; Oleg Pustovyy; Ludmila Globa; Randy J Kulesza; Iryna Sorokulova
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.